FIDELITY FUNDS减持昭衍新药(06127)57.66万股 每股作价约24.56港元

Group 1 - Fidelity Funds reduced its holdings in Zhaoyan New Drug (06127) by 576,600 shares at a price of HKD 24.5563 per share, totaling approximately HKD 14.1592 million [1] - After the reduction, Fidelity Funds holds a total of 14.9212 million shares, representing a 12.54% ownership stake [1]